eli lily glp 1 FDA asks Lilly for more safety data on weight loss pill Foundayo Lilly's Double-Beat Widens the GLP-1

Gastrointestinal (GI) side effects are common in people with diabetes treated both with metformin and with GLP-1 receptor agonists (GLP-1RAs), and they

The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.

Discover how GLP-1 medications may help manage PCOS by improving insulin resistance, supporting weight loss, and restoring hormonal balance

Discover the causes of itching and skin reactions with Ozempic, when to seek medical advice, and practical tips to manage injection site reactions and pruritus safely.

Prebiotic Fiber Gummies

Purpose of Review To discuss current literature and provide practical recommendations for the safe and effective use of glucagon-like peptide 1 receptor agonists (GLP-1 RA) in people with inflammatory bowel disease (IBD) and type 2 diabetes (T2D) and/or obesity